Engineering anti-cancer nanovaccine based on antigen cross-presentation
10.1042/BSR20193220
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
Portland Press Ltd
2021
|
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/209926 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-209926 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2099262024-04-04T03:59:22Z Engineering anti-cancer nanovaccine based on antigen cross-presentation Warrier, V.U. Makandar, A.I. Garg, M. Sethi, G. Kant, R. Pal, J.K. Yuba, E. Gupta, R.K. PHARMACOLOGY 10.1042/BSR20193220 Bioscience Reports 39 10 BSR20193220 2021-12-09T03:01:02Z 2021-12-09T03:01:02Z 2019 Review Warrier, V.U., Makandar, A.I., Garg, M., Sethi, G., Kant, R., Pal, J.K., Yuba, E., Gupta, R.K. (2019). Engineering anti-cancer nanovaccine based on antigen cross-presentation. Bioscience Reports 39 (10) : BSR20193220. ScholarBank@NUS Repository. https://doi.org/10.1042/BSR20193220 0144-8463 https://scholarbank.nus.edu.sg/handle/10635/209926 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ Portland Press Ltd Scopus OA2019 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| description |
10.1042/BSR20193220 |
| author2 |
PHARMACOLOGY |
| author_facet |
PHARMACOLOGY Warrier, V.U. Makandar, A.I. Garg, M. Sethi, G. Kant, R. Pal, J.K. Yuba, E. Gupta, R.K. |
| format |
Review |
| author |
Warrier, V.U. Makandar, A.I. Garg, M. Sethi, G. Kant, R. Pal, J.K. Yuba, E. Gupta, R.K. |
| spellingShingle |
Warrier, V.U. Makandar, A.I. Garg, M. Sethi, G. Kant, R. Pal, J.K. Yuba, E. Gupta, R.K. Engineering anti-cancer nanovaccine based on antigen cross-presentation |
| author_sort |
Warrier, V.U. |
| title |
Engineering anti-cancer nanovaccine based on antigen cross-presentation |
| title_short |
Engineering anti-cancer nanovaccine based on antigen cross-presentation |
| title_full |
Engineering anti-cancer nanovaccine based on antigen cross-presentation |
| title_fullStr |
Engineering anti-cancer nanovaccine based on antigen cross-presentation |
| title_full_unstemmed |
Engineering anti-cancer nanovaccine based on antigen cross-presentation |
| title_sort |
engineering anti-cancer nanovaccine based on antigen cross-presentation |
| publisher |
Portland Press Ltd |
| publishDate |
2021 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/209926 |
| _version_ |
1800915197273047040 |